BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heinsbroek E, Tafatatha T, Phiri A, Swarthout TD, Alaerts M, Crampin AC, Chisambo C, Mwiba O, Read JM, French N. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination. Vaccine 2018;36:7369-76. [PMID: 30352744 DOI: 10.1016/j.vaccine.2018.10.021] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Klugman KP, Rodgers GL. Population versus individual protection by pneumococcal conjugate vaccination. Lancet 2019;393:2102-4. [PMID: 31000193 DOI: 10.1016/S0140-6736(19)30039-X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lewnard JA, Lo NC, Arinaminpathy N, Frost I, Laxminarayan R. Childhood vaccines and antibiotic use in low- and middle-income countries. Nature 2020;581:94-9. [PMID: 32376956 DOI: 10.1038/s41586-020-2238-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
3 Soeters HM, Kambiré D, Sawadogo G, Ouédraogo-Traoré R, Bicaba B, Medah I, Sangaré L, Ouédraogo AS, Ouangraoua S, Yaméogo I, Congo-Ouédraogo M, Ky Ba A, Aké F, Velusamy S, McGee L, Van Beneden C, Whitney CG. Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination. Vaccine 2020;38:5726-33. [PMID: 32591290 DOI: 10.1016/j.vaccine.2020.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Thindwa D, Wolter N, Pinsent A, Carrim M, Ojal J, Tempia S, Moyes J, Mcmorrow M, Kleynhans J, Gottberg AV, French N, Cohen C, Flasche S, Althouse B; PHIRST group. Estimating the contribution of HIV-infected adults to household pneumococcal transmission in South Africa, 2016–2018: A hidden Markov modelling study. PLoS Comput Biol 2021;17:e1009680. [DOI: 10.1371/journal.pcbi.1009680] [Reference Citation Analysis]
5 Kaboré L, Adebanjo T, Njanpop-Lafourcade BM, Ouangraoua S, Tarbangdo FT, Meda B, Velusamy S, Bicaba B, Aké F, McGee L, Yaro S, Betsem E, Gervaix A, Gessner BD, Whitney CG, Moïsi JC, Van Beneden CA. Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys. J Infect Dis 2021;224:S258-66. [PMID: 34469552 DOI: 10.1093/infdis/jiab037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nyazika TK, Law A, Swarthout TD, Sibale L, Ter Braake D, French N, Heyderman RS, Everett D, Kadioglu A, Jambo KC, Neill DR. Influenza-like illness is associated with high pneumococcal carriage density in Malawian children. J Infect 2020;81:549-56. [PMID: 32711042 DOI: 10.1016/j.jinf.2020.06.079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kalata NL, Nyazika TK, Swarthout TD, Everett D, French N, Heyderman RS, Gordon SB, Jambo KC. Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000-2019: protocol for systematic review. BMJ Open 2019;9:e030981. [PMID: 31727654 DOI: 10.1136/bmjopen-2019-030981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nisar MI, Ahmed S, Jehan F, Shahid S, Shakoor S, Kabir F, Hotwani A, Munir S, Muhammad S, Khalid F, Althouse B, Hu H, Whitney C, Ali A, Zaidi AKM, Omer SB, Iqbal N. Direct and indirect effect of 10 valent pneumococcal vaccine on nasopharyngeal carriage in children under 2 years of age in Matiari, Pakistan. Vaccine 2021;39:1319-27. [PMID: 33422379 DOI: 10.1016/j.vaccine.2020.12.066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chan J, Nguyen CD, Dunne EM, Kim Mulholland E, Mungun T, Pomat WS, Rafai E, Satzke C, Weinberger DM, Russell FM. Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries. Vaccine 2019;37:6299-309. [PMID: 31500968 DOI: 10.1016/j.vaccine.2019.08.073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Lourenço J, Obolski U, Swarthout TD, Gori A, Bar-Zeev N, Everett D, Kamng'ona AW, Mwalukomo TS, Mataya AA, Mwansambo C, Banda M, Gupta S, French N, Heyderman RS. Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study. BMC Med 2019;17:219. [PMID: 31801542 DOI: 10.1186/s12916-019-1450-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
11 Kapumba BM, Jambo K, Rylance J, Gmeiner M, Sambakunsi R, Parker M, Gordon SB, Gooding K. Stakeholder views on the acceptability of human infection studies in Malawi. BMC Med Ethics 2020;21:14. [PMID: 32024497 DOI: 10.1186/s12910-020-0454-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 [DOI: 10.1101/477695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Madhi SA, Nzenze SA, Nunes MC, Chinyanganya L, Van Niekerk N, Kahn K, Twine R, De Gouveia L, Von Gottberg A, Shiri T. Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization. Expert Rev Vaccines 2020;19:383-93. [PMID: 32237932 DOI: 10.1080/14760584.2020.1750377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Swarthout TD, Ibarz-Pavon A, Kawalazira G, Sinjani G, Chirombo J, Gori A, Chalusa P, Bonomali F, Nyirenda R, Bulla E, Brown C, Msefula J, Banda M, Kachala J, Mwansambo C, Henrion MY, Gordon SB, French N, Heyderman RS. A pragmatic health centre-based evaluation comparing the effectiveness of a PCV13 schedule change from 3+0 to 2+1 in a high pneumococcal carriage and disease burden setting in Malawi: a study protocol. BMJ Open 2021;11:e050312. [PMID: 34140345 DOI: 10.1136/bmjopen-2021-050312] [Reference Citation Analysis]
15 Swarthout TD, Fronterre C, Lourenço J, Obolski U, Gori A, Bar-Zeev N, Everett D, Kamng'ona AW, Mwalukomo TS, Mataya AA, Mwansambo C, Banda M, Gupta S, Diggle P, French N, Heyderman RS. High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi. Nat Commun 2020;11:2222. [PMID: 32376860 DOI: 10.1038/s41467-020-15786-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
16 Uddén F, Filipe M, Slotved HC, Yamba-Yamba L, Fuursted K, Pintar Kuatoko P, Larsson M, Bjurgert J, Månsson V, Pelkonen T, Reimer Å, Riesbeck K. Pneumococcal carriage among children aged 4 - 12 years in Angola 4 years after the introduction of a pneumococcal conjugate vaccine. Vaccine 2020;38:7928-37. [PMID: 33143954 DOI: 10.1016/j.vaccine.2020.10.060] [Reference Citation Analysis]
17 Chaguza C, Heinsbroek E, Gladstone RA, Tafatatha T, Alaerts M, Peno C, Cornick JE, Musicha P, Bar-Zeev N, Kamng'ona A, Kadioglu A, McGee L, Hanage WP, Breiman RF, Heyderman RS, French N, Everett DB, Bentley SD. Early Signals of Vaccine-driven Perturbation Seen in Pneumococcal Carriage Population Genomic Data. Clin Infect Dis 2020;70:1294-303. [PMID: 31094423 DOI: 10.1093/cid/ciz404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Neal EFG, Nguyen CD, Ratu FT, Dunne EM, Kama M, Ortika BD, Boelsen LK, Kado J, Tikoduadua L, Devi R, Tuivaga E, Reyburn RC, Satzke C, Rafai E, Mulholland EK, Russell FM. Factors associated with pneumococcal carriage and density in children and adults in Fiji, using four cross-sectional surveys. PLoS One 2020;15:e0231041. [PMID: 32236150 DOI: 10.1371/journal.pone.0231041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
19 Mills RO, Abdullah MR, Akwetey SA, Sappor DC, Cole I, Baffuor-Asare M, Bolivar JA, Gámez G, van der Linden MPG, Hammerschmidt S. Post-Vaccination Streptococcus pneumoniae Carriage and Virulence Gene Distribution among Children Less Than Five Years of Age, Cape Coast, Ghana. Microorganisms 2020;8:E1987. [PMID: 33322236 DOI: 10.3390/microorganisms8121987] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Lourenço J, Daon Y, Gori A, Obolski U. Pneumococcal Competition Modulates Antibiotic Resistance in the Pre-Vaccination Era: A Modelling Study. Vaccines (Basel) 2021;9:265. [PMID: 33809706 DOI: 10.3390/vaccines9030265] [Reference Citation Analysis]
21 Usuf E, Christian B, Gladstone R, Bojang E, Jawneh K, Cox I, Jallow E, Bojang A, Greenwood B, Adegbola RA, Bentley SD, Hill PC, Roca A. Persistent and emerging pneumococcal carriage serotypes in a rural Gambian community after ten years of pneumococcal conjugate vaccine pressure. Clin Infect Dis 2020:ciaa856. [PMID: 32584973 DOI: 10.1093/cid/ciaa856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Prayitno A, Supriyatno B, Munasir Z, Karuniawati A, Hadinegoro SRS, Prihartono J, Safari D, Sundoro J, Khoeri MM. Pneumococcal nasopharyngeal carriage in Indonesia infants and toddlers post-PCV13 vaccination in a 2+1 schedule: A prospective cohort study. PLoS One 2021;16:e0245789. [PMID: 33497405 DOI: 10.1371/journal.pone.0245789] [Reference Citation Analysis]
23 Bar-Zeev N, Swarthout TD, Everett DB, Alaerts M, Msefula J, Brown C, Bilima S, Mallewa J, King C, von Gottberg A, Verani JR, Whitney CG, Mwansambo C, Gordon SB, Cunliffe NA, French N, Heyderman RS; VacSurv Consortium. Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studies. Lancet Glob Health 2021;9:e989-98. [PMID: 34143997 DOI: 10.1016/S2214-109X(21)00165-0] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Coughtrie AL, Jefferies JM, Cleary DW, Doncaster CP, Faust SN, Kraaijeveld AR, Moore MV, Mullee MA, Roderick PJ, Webb JS, Yuen HM, Clarke SC. Microbial epidemiology and carriage studies for the evaluation of vaccines. Journal of Medical Microbiology 2019;68:1408-18. [DOI: 10.1099/jmm.0.001046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Kamthunzi P. Impact of PCV13 vaccination in Blantyre, Malawi. Lancet Glob Health 2021;9:e893-4. [PMID: 34143985 DOI: 10.1016/S2214-109X(21)00258-8] [Reference Citation Analysis]
26 Muhandule Birindwa A, Gonzales-Siles L, Nordén R, Geravandi S, Tumusifu Manegabe J, Morisho L, Saili Mushobekwa S, Andersson R, Skovbjerg S. High bacterial and viral load in the upper respiratory tract of children in the Democratic Republic of the Congo. PLoS One 2020;15:e0240922. [PMID: 33119683 DOI: 10.1371/journal.pone.0240922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Abotsi RE, Nicol MP, McHugh G, Simms V, Rehman AM, Barthus C, Mbhele S, Moyo BW, Ngwira LG, Mujuru H, Makamure B, Mayini J, Odland JØ, Ferrand RA, Dube FS. Prevalence and antimicrobial resistance profiles of respiratory microbial flora in African children with HIV-associated chronic lung disease. BMC Infect Dis 2021;21:216. [PMID: 33632144 DOI: 10.1186/s12879-021-05904-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Thindwa D, Pinsent A, Ojal J, Gallagher KE, French N, Flasche S. Vaccine strategies to reduce the burden of pneumococcal disease in HIV-infected adults in Africa. Expert Rev Vaccines 2020;19:1085-92. [PMID: 33269987 DOI: 10.1080/14760584.2020.1843435] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]